Bariatric surgery may result in significant cardiometabolic improvements, particularly among younger, female, or white people and those without comorbidities, according to new research published in the Journal of the Endocrine Society. The United States has the highest obesity rates globally. In 2017 – 2018, about 40% of U.S. adults had obesity and 9% had severe obesity. The prevalence is...
When Evan D. Rosen, MD, PhD, first began researching adipose biology many years ago, not much was known about it and its impacts on so many diseases. He talks to Endocrine News about how far the science has advanced regarding adipose tissue as well as his own lab’s research, the importance of collaboration, and why...
Laurence Katznelson, MD, a national leader in graduate medical education and a distinguished physician-scientist in endocrinology and metabolism, will join Cedars-Sinai as vice dean of Medical Education on May 1. Katznelson will oversee Cedars-Sinai’s Graduate Medical Education, Continuing Medical Education, the Women’s Guild Simulation Center for Advanced Clinical Skills, the Chuck Lorre School of Allied Health, and...
The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several...
Children who are physically inactive may have high cholesterol in early adulthood and subsequent heart health issues in their mid-forties, according to new research published in The Journal of Clinical Endocrinology & Metabolism. Study author Andrew O. Agbaje, MD, MPH, FESC, talks to Endocrine News about the study’s findings, the arbitrary nature of some guidelines,...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Sandoz Receives FDA Approval for Denosumab Biosimilars On March 5, Sandoz announced that the U.S. Food and Drug Administration (FDA) approved Wyost® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz), the first and only FDA-approved denosumab biosimilars, to treat all indications of the reference medicines. Keren Haruvi,...
Endocrine Society members elected Carol Lange, PhD, of the University of Minnesota in Minneapolis, Minn., as its 2025-2026 president. She will serve as president-elect for a year beginning in June 2024 before becoming President in June 2025. A professor of medicine and molecular pharmacology and therapeutics, Lange also holds the Tickle Family Land Grant Endowed...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Exact Sciences Launches Riskguard™ Hereditary Cancer Test in the U.S. On February 27, Exact Sciences Corp., announced the launch of the Riskguard™ hereditary cancer test in the United States. The Riskguard test provides an individualized patient report that includes gene specific...